comparemela.com

Latest Breaking News On - Zuma 2 trial - Page 1 : comparemela.com

Current Treatment Options in Third-line MCL

Experts on mantle cell lymphoma discuss third-line treatment options available for patients.

Recent-updates
Follicular-lymphoma
Mantle-cell-lymphoma
Treatment-options
Cmcl
Third-line
Third-line-mcl
Cart-cells
Zuma-2
Brexu-cel
Zuma-2-trial

Brexu-Cel Induces Responses in Real-World Population of High-Risk R/R MCL

Brexucabtagene autoleucel is safe and effective in real-world patients with relapsed/refractory mantle cell lymphoma, regardless of the presence of high-risk features.

United-states
California
Swetha-kambhampati
Genentech
Mantle-cell-lymphoma-international-prognostic-index
Marrow-transplant-research
Division-of-lymphoma
International-blood
Department-of-hematology
Hematopoietic-cell-transplantation
Published-july
Brexucabtagene-autoleucel

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.